At 22nd Century, our important mission is straightforward: to reduce the harm caused by smoking.
To this end, our proprietary genetic engineering technology and plant breeding expertise allow us to control the level of nicotine (and other nicotinic alkaloids) in the tobacco plant. As a result, we are able to grow tobacco with up to 97% less nicotine than conventional tobacco – as well as tobacco plants with relatively high nicotine levels. The applications for this technology are extraordinary; our very low nicotine (“VLN”) tobacco has demonstrated remarkable efficacy as a smoking cessation aid. On the other hand, for smokers who do not wish to quit, our high nicotine tobacco enables us to produce a cigarette with what we believe is the world’s lowest tar-to-nicotine ratio.
22nd Century is actively seeking strategic business relationships with companies that share our mission of reducing the harm caused by smoking.